Interpretation of NCCN Guidelines: General Therapies on Non-small Cell Lung Cancer (Version 6. 2015)
Lung cancer is one of the most common malignant tumors in China and ranks the first of cancer-related death. The major etiological agent of lung cancer is an industry-made and promoted addictive product, so lung cancer is considered to be a unique disease in all cancers. Effective policies for publi...
Main Author: | Xin-en HUANG |
---|---|
Format: | Article |
Language: | English |
Published: |
Third Party Medicine International Publishing Group Co. Limited
2015-06-01
|
Series: | Journal of International Translational Medicine |
Subjects: | |
Online Access: | http://www.jitm.hk/EN/abstract/abstract153.shtml |
Similar Items
-
Interpretation of NCCN Guideline: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Version 1, 2017)
by: Lei XIA, et al.
Published: (2016-12-01) -
Chemotherapy in non-small cell lung cancer: opportunities for advancement
by: Mani Akhtari, et al.
Published: (2016-06-01) -
Combining two different chemotherapy agents with platinum analogs as induction and consolidation regimes in nonsmall cell lung carcinoma
by: Mohsin Khan, et al.
Published: (2017-01-01) -
Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis
by: Qi J, et al.
Published: (2019-12-01) -
Role of surgery in patients with early stage small-cell lung cancer
by: Peng A, et al.
Published: (2019-07-01)